|
Product complaint # (b)(4).Date sent to the fda: 1/22/2020.Evaluation: an open sample of (b)(4), lot # jaz476 was returned for analysis.During the visual inspection of sample, the suture has begun with the process of degradation and the strand was broken in multiples pieces, this is the cause that breakage suture.The (b)(4) contains absorbable sutures and as the sample was received open, the time of exposure of suture to the environment could not be determined and no functional test can be performed due to sample condition.The foil was inspected and multiples holes in cavity were noted.This condition contributed to degradation of the suture.The conditions of the holes could not be determined.The manufacturing records were reviewed, and the manufacturing/packaging criteria were met prior to the release of this batch.Per the sample condition the assignable cause of performance breakage suture, was caused by suture degradation exposure to environment and the reported complaint was observed.A manufacturing record evaluation was performed for the finished device batch number, and no non-conformance's were identified.Additional information has been requested and obtained: are these possible lots for hmk384, jaz476? hmk384 is the lot number of the affected device.Besides the product with hmk384, the hospital returned one unopened package with jaz476.We do not know if it has a problem.Anyway, the both packages (opened one with hmk384, and unopened one with jaz476) were shipped was one device from each lot involved in the event? please see the above comment.Status device return, follow-up? the device has been received at sukagawa and shipped.Please check rmao.No further information will be provided.
|